Home / Inspections / 1287792

FDA Inspection 1287792 — Joseph S. Gimbel, MD

Joseph S. Gimbel, MD — FEI 3002917254

The FDA completed an inspection of Joseph S. Gimbel, MD on October 10, 2025 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 10, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Phoenix, AZ (United States)

Additional Details

Clinical Investigator (CI)

Facility

Other inspections at this facility

  • 1106749 (NAI Wed Oct 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1048846 (NAI Thu Apr 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 931953 (NAI Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865172 (VAI Thu Jan 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 796271 (VAI Mon Aug 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources